e-ISSN 1726-6890
p-ISSN 1735-0328
Citation data
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
9 resultsUpdated October 23, 2026
1
Real-time impact of COVID-19 pandemic on cutaneous leishmaniasis case finding and strategic planning, preventive interventions, control and epidemiology in a region with a high burden of cutaneous leishmaniasis and COVID-19: A cross-sectional descriptive study based on registry data in Ilam-Iran
Health Science Reports
August 2023
Shams M.
Open Access
2
Nrf2 as one of the potential targets in multiple sclerosis
Advances in Health and Disease Volume 57
1 August 2022
Shirooie S.
3
A Critical Review on Recent Heterocyclics Identified for Anti-Leishmanial Therapy
Current Chemical Biology
June 2022
Rathore S.
4
Ciprofloxacin-Tethered 1,2,3-Triazole Conjugates: New Quinolone Family Compounds to Upgrade Our Antiquated Approach against Bacterial Infections
ACS Omega
25 January 2022
Agarwal A.
Open Access
5
1,3,4-thiadiazole: A Privileged Scaffold for Drug Design and Development
Current Topics in Medicinal Chemistry
November 2021
Han X.
6
Synthesis, study of antileishmanial and antitrypanosomal activity of imidazo pyridine fused triazole analogues
Rsc Advances
19 October 2020
Nandikolla A.
Open Access
7
Synthesis and evaluation of thiadiazole-based antileishmanial agents
Journal of Reports in Pharmaceutical Sciences
July-December 2020
Hassanzadeh F.
8
Novel 5-(Nitrothiophene-2-yl)-1,3,4-thiadiazole derivatives: Synthesis and antileishmanial activity against promastigote stage of leishmania major
Iranian Journal of Pharmaceutical Research
Autumn 2019
Sadat-Ebrahimi S.E.
9
Synthesis and characterization of some new 1,3,4-thiadiazole compounds derived from 3,4-(Methylenedioxy)cinnamic acid and their antimicrobial activities
Letters in Organic Chemistry
2019
Muğlu H.
All Open Access, Green